Outcomes from a Canadian public health prenatal screening program for hepatitis B: 1997-2004

Canadian Journal of Public Health

Volumn 98, Issue 3, 2007, Pages 194-197

  Plitt, Sabrina S ^a,b   Somily, Ali M ^c   Singh, Ameeta E ^b,d  

^a PUBLIC HEALTH AGENCY OF CANADA   (Canada)

^b UNIVERSITY OF ALBERTA   (Canada)

^c KING SAUD UNIVERSITY   (Saudi Arabia)

^d Alberta Health and Wellness   (Canada)

Author keywords

Hepatitis B virus; Immunization; Prenatal care; Serologic tests; Vertical transmission

Indexed keywords

EID: 34447277876     PISSN: 00084263     EISSN: None     Source Type: Journal    
DOI: 10.1007/bf03403711     Document Type: Review

References (20)

1. NACI. Canadian Immunization Guide, 6th edition. Canadian Medical Institution, 2002.
2. Tran TT, Martin P. Hepatitis B: Epidemiology and natural history. Clin Liver Dis 2004;8(2):255-66.
3. Stevens CE, Taylor PE, Tong MJ, Toy PT, Vyas GN, Nair PV, et al. Yeast-recombinant hepatitis B vaccine. Efficacy with hepatitis B immune globulin in prevention of perinatal hepatitis B virus transmission. JAMA 1987;257(19):2612-16.
4. Beasley RP, Hwang LY, Lee GC, Lan CC, Roan CH, Huang FY, et al. Prevention of perinatally transmitted hepatitis B virus infections with hepatitis B imuneglobulin and hepatitis B vaccine. Lancet 1983;2(8359):1099-102.
5. Alberta Bloodborne Pathogens Surveillance Working Group, Alberta Bloodborne Pathogens Surveillance Report. Alberta Health and Wellness: Edmonton, AB, 2003.
6. Minuk G, Uhanova J. Chronic hepatitis B in Canada. Can J Infect Dis 2001;12(6):351-56.
7. Zhang J, Zou S, Giulivi A. Hepatitis B in Canada. CCDR 2001;27S3:10-12.
8. Henning KJ, Pollack DM, Friedman SM. A neonatal hepatitis B surveillance and vaccination program: New York City, 1987 to 1988. Am J Public Health 1992;82(6):885-88.
9. Kohn MA, Farley TA, Scott C. The need for more aggressive follow-up of children born to hepatitis B surface antigen-positive mothers: Lessons from the Louisiana Perinatal Hepatitis B Immunization Program. Pediatr Infect Dis J 1996;15(6):535-40.
10. Chernesky MA, Blajchman MA, Castriciano S, Basbaum J, Spiak C, Mahoney JB. Analysis of a pregnancy-screening and neonatal-immunization program for hepatitis B in Hamilton, Ontario, Canada, 1977-1988. J Med Virol 1991;35(1):50-54.
11. Okun NB, Larke RP, Waters JR, Joffres MR. Success of a program of routine prenatal screening for hepatitis B surface antigen: The first 2 years. CMAJ 1990;143(12):1317-21.
12. Wong S, Chan LY, Yu V, Ho L. Hepatitis B carrier and perinatal outcome in singleton pregnancy. Am J Perinatol 1999; 16(9):485-88.
13. del Canho R, Grosheide PM, Mazel JA, Heijtink RA, Hop WC, Gerards LJ, et al., Ten-year neonatal hepatitis B vaccination program, The Netherlands, 1982-1992: Protective efficacy and long-term immunogenicity. Vaccine 1997;15(15):1624-30.
14. Mandelbrot L, Newell M-L, Vertical transmission of hepatitis viruses. In: Newell M-L, McIntyre J (Eds.), Congenital and Perinatal Infections: Prevention, Diagnosis and Treatment. Cambridge, UK: Cambridge University Press, 2000;164-204.
15. Lee SD, Lo KJ, Tsai YT, Wu JC. Maternal hepatitis B virus DNA in mother-infant transmission. Lancet 1989;1(8640):719.
16. Burk RD, Hwang LY, Ho GY, Shafritz DA, Beasley RP. Outcome of perinatal hepatitis B virus exposure is dependent on maternal virus load. J Infect Dis 1994;170(6):1418-23.
17. del Canho R, Grosheide PM, Schalm SW, de Vries RR, Heijtink RA. Failure of neonatal hepatitis B vaccination: The role of HBV-DNA levels in hepatitis B carrier mothers and HLA antigens in neonates. J Hepatol 1994;20(4):483-86.
18. Corneil T, Gilbert M, Buxton J, Krajden M, McNabb G, McIntyre C. The Use of Routine HBeAg Testing in Pregnant Women in British Columbia to Identify Those Infants at Highest Risk for Vertical Transmission. Presented at the 6th Annual Canadian Immunization Conference. Montreal, Canada, 2004.
19. Reproductive Health Report Working Group, Alberta Reproductive Health: Pregnancies and Births 2004. Alberta Health and Wellness: Edmonton, AB.
20. van Zonneveld M, van Nunen AB, Niesters HG, de Man RA, Schalm SW, Janssen HL. Lamivudine treatment during pregnancy to prevent perinatal transmission of hepatitis B virus infection. J Viral Hepat 2003;10(4):294-97.